Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arcturus Therapeutics Ltd (NASDAQ:ARCT)

8.87
Delayed Data
As of Nov 21
 +0.0701 / +0.80%
Today’s Change
5.81
Today|||52-Week Range
18.04
-39.66%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Arcturus Therapeutics Ltd have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a -77.45% decrease from the last price of 8.87.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Outperform stock in Arcturus Therapeutics Ltd. This rating has held steady since November, when it was unchanged from a Outperform rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
$0.00
Reporting Date
Feb 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 22.22%
 
 
 
 
 
 
Growthannually -293.26%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.